Sacral Nerve Stimulation devices are anticipated to grow the fastest with CAGR of 18.7% from 2015 to 2019. Increasing incidence of fecal and urinary incontinence in North America and Europe is a significant growth driver for this device segment. The rise in incidence subsequently has been estimated largely aided by the aging population in the developed regions.